Why is Emcure Pharma falling/rising?

As of 26-Aug, Emcure Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 1,458.40, which reflects a decrease of Rs 29.6 or 1.99%. The stock has been losing value for the last two days, with a total drop of 2.37% during this period. It touched an intraday low of Rs 1,443.7, indicating a significant downward movement. Despite having a high management efficiency and strong financial metrics, such as a low Debt to EBITDA ratio and positive results over the last four quarters, the stock's performance has been hindered by falling investor participation, particularly from institutional investors, who have reduced their stake by 0.81% in the last quarter.
In the broader market context, Emcure's short-term performance has been relatively better than the benchmark, with a 1-week return of -0.68% compared to the Sensex's -1.05%. However, the stock's longer-term performance shows a mixed picture, with a 1-month return of +3.45% against the Sensex's -0.83%. The decline in delivery volume and the stock's recent consecutive falls suggest a lack of confidence among investors, which is compounded by concerns over poor long-term growth prospects despite the company's recent profitability. Overall, while the stock has shown some resilience in the past, current trends indicate a challenging environment for Emcure Pharmaceuticals Ltd.